Brincidofovir

Brincidofovir is an antiviral medication that is used to treat certain viral infections. It is a lipid conjugate of cidofovir, which is an antiviral drug used to treat cytomegalovirus (CMV) infections. Brincidofovir is designed to have improved pharmacokinetic properties compared to cidofovir, allowing for oral administration and reduced toxicity.
Mechanism of Action[edit]
Brincidofovir works by inhibiting viral DNA polymerase, an enzyme critical for viral DNA replication. By interfering with this enzyme, brincidofovir prevents the replication of viral DNA, thereby inhibiting the proliferation of the virus within the host organism. This mechanism is similar to that of cidofovir, but the lipid conjugation in brincidofovir allows it to be more effectively absorbed and utilized by the body.
Clinical Uses[edit]
Brincidofovir is primarily used in the treatment of infections caused by double-stranded DNA viruses. It has shown efficacy against a range of viruses, including:
- Cytomegalovirus (CMV)
- Adenovirus
- Smallpox
- Herpes simplex virus (HSV)
The drug is particularly valuable in immunocompromised patients, such as those undergoing hematopoietic stem cell transplantation, who are at higher risk for severe viral infections.
Development and Approval[edit]
Brincidofovir was developed by Chimerix, a biopharmaceutical company. It has undergone various clinical trials to assess its safety and efficacy. The drug has been granted orphan drug status for the treatment of certain viral infections, which provides incentives for the development of treatments for rare diseases.
Side Effects[edit]
Common side effects of brincidofovir include gastrointestinal symptoms such as diarrhea, nausea, and vomiting. These side effects are generally mild to moderate in severity. Unlike cidofovir, brincidofovir does not require co-administration with probenecid or intravenous hydration, which are used to mitigate the nephrotoxic effects of cidofovir.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian